Alterity Therapeutics Limited Stock Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
04:30:00 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -1.10% |
|
-3.43% | +46.43% |
| Market Cap | 81.15M 69.93M 65.56M 59.85M 113M 7.76B 113M 778M 303M 3.92B 305M 298M 12.98B | P/E 2027 * |
-0.4x | P/E 2028 * | -0.4x |
|---|---|---|---|---|---|
| Enterprise Value | 40.25M 34.68M 32.52M 29.68M 55.92M 3.85B 56.1M 386M 151M 1.94B 151M 148M 6.44B | EV / Sales 2027 * |
19.3x | EV / Sales 2028 * | 13.7x |
| Free-Float |
92.18% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Alterity Therapeutics Limited
| 1 day | -1.10% | ||
| 1 week | -3.43% | ||
| Current month | +2.15% | ||
| 1 month | -1.20% | ||
| 3 months | +10.54% | ||
| 6 months | +31.07% | ||
| Current year | +46.43% |
| 1 week | 4.4 |  | 5.01 |
| 1 month | 4.2 | | 5.04 |
| Current year | 3.02 | | 5.89 |
| 1 year | 2.66 | | 5.89 |
| 3 years | 1 | | 7 |
| 5 years | 1 | | 14 |
| 10 years | 1 | | 54 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Macnish
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | -3.43% | - | - | 81.15M | |
| -0.78% | -1.42% | +2.49% | +22.78% | 50.47B | |
| -6.00% | -0.75% | +442.41% | +544.39% | 44.56B | |
| -0.24% | +0.74% | +38.69% | +18.02% | 43.08B | |
| -1.55% | -2.07% | +23.08% | +81.47% | 41.7B | |
| -0.31% | -0.83% | +16.15% | +51.42% | 33.21B | |
| -1.79% | -3.24% | +27.00% | +129.56% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.60% | +27.75% | 14.58B | |
| -1.66% | -1.25% | +78.59% | +46.66% | 13.92B | |
| Average | -1.49% | -1.06% | +80.00% | +115.26% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.06% | +95.71% | +133.63% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.09M 1.8M 1.69M 1.54M 2.9M 200M 2.91M 20.04M 7.82M 101M 7.85M 7.68M 334M | 3.21M 2.77M 2.59M 2.37M 4.46M 307M 4.47M 30.76M 12M 155M 12.05M 11.79M 513M |
| Net income | -29.99M -25.84M -24.23M -22.12M -41.67M -2.87B -41.8M -287M -112M -1.45B -113M -110M -4.8B | -33.6M -28.95M -27.15M -24.78M -46.68M -3.21B -46.83M -322M -126M -1.62B -126M -123M -5.38B |
| Net Debt | -40.9M -35.25M -33.05M -30.17M -56.83M -3.91B -57.01M -392M -153M -1.97B -154M -150M -6.54B | -37.15M -32.01M -30.02M -27.4M -51.62M -3.55B -51.78M -356M -139M -1.79B -139M -136M -5.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$4.510 | -1.10% | 11,729 |
| 27/08/26 | US$4.560 | -4.60% | 22,762 |
| 26/08/26 | US$4.780 | +6.94% | 63,474 |
| 25/08/26 | US$4.470 | -2.19% | 21,760 |
| 24/08/26 | US$4.570 | -2.14% | 10,596 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
Select your edition
All financial news and data tailored to specific country editions
